Candel Therapeutics CADL
NASDAQ CADL
$8.37 +0.00 (+0.00%)
As of: Oct 22, 2026 · 3:59 PM EDT

Candel Therapeutics (CADL) Other financing activities (2025)

Updated

Candel Therapeutics' Other financing activities came in at -$178,000 for Q4 2025.

Analysis

Candel Therapeutics (CADL) Other financing activities (2025) Analysis & Trends

For FY2023, Candel Therapeutics' Other financing activities was $121,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Candel Therapeutics 618.25 Mn 109.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 178,000.00
API Access

Candel Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CADL&period=max&api_key=YOUR_API_KEY